ADAM17 and infection: Down regulation of ADAM17 inhibition may also impair the immune responses and increase the susceptibility to infections, due to imbalance in the release of CD14, CD16 via monocytes (Waller et al., 2019), natural killer cells, and T cells and also due to impaired neutrophil infiltration at the sites of infection.